Amgen becomes 10th drugmaker to restrict 340B discounts to safety net hospitals

(By Katie Adams for Becker’s Hospital Review)

Beginning Jan. 3, Amgen will curtail drug discounts to safety net hospitals’ contract pharmacies under the federal 340B program, Endpoints News reported Dec. 2.

Moving forward, the drugmaker will allow 340B hospitals to select only one pharmacy location. This excludes federal grantees as well as contract pharmacies owned entirely by a 340B hospital or that have common ownership with a health system. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org